Rolli A, Favaro L, Aurier E, Tagliavini S, Ciarlini E, Brizzi M P, Botti G
G Ital Cardiol. 1980;10(4):444-51.
MB isoenzyme of creatine kinase was measured every 3 hours during the first 24 hours of admission to C.C.U. and successively every 4-6 hours in the next 24-48 hours in 42 patients with acute transmural myocardial infarction. The pain-C.C.U. admission time interval was less than 6 hours in all cases. 22 patients were treated by propranolol (2 mg bolus followed by 0.1 mg/Kg/die for the next 48 hours in continuous i.v. infusion), 20 patients served as a control. Cumulated activity, peak plasma value, rate of release and total duration of release of MB-CK did not differ significantly between the two groups. In patients treated within 3 hours from pain onset (n = 12) cumulated activity, peak plasma value and rate of release of MB-CK were significantly inferior than control group. In patients treated between the 3rd and 6th hour from pain onset (n = 10) the total duration of release of isoenzyme was significantly prolonged. No treated patients developed clinical or radiologic signs of cardiac insufficiency. The incidence of ventricular arrhythmias was 17% in the treated group vs. 62% in the control group (P < 0.05). The data show that propranolol, if started early in the course of acute myocardial infarction, reduces significantly infarct size and slows down the evolution of necrotic process.
对42例急性透壁性心肌梗死患者,在入住冠心病监护病房(C.C.U.)的头24小时内,每3小时测定一次肌酸激酶的MB同工酶,在接下来的24 - 48小时内,依次每4 - 6小时测定一次。所有病例中疼痛至入住C.C.U.的时间间隔均小于6小时。22例患者接受普萘洛尔治疗(先静脉推注2毫克,随后在接下来的48小时内以0.1毫克/千克/天的剂量持续静脉输注),20例患者作为对照。两组之间MB - CK的累积活性、血浆峰值、释放速率和总释放持续时间无显著差异。在疼痛发作后3小时内接受治疗的患者(n = 12)中,MB - CK的累积活性、血浆峰值和释放速率显著低于对照组。在疼痛发作后第3至6小时接受治疗的患者(n = 10)中,同工酶的总释放持续时间显著延长。接受治疗的患者均未出现心脏功能不全的临床或放射学征象。治疗组室性心律失常的发生率为17%,而对照组为62%(P < 0.05)。数据表明,普萘洛尔如果在急性心肌梗死病程早期开始使用,可显著减小梗死面积并减缓坏死过程的进展。